Advertisement
News
Subscribe to MDT Magazine News

Health System’s Programs Merit ‘Blue’ Rating

November 23, 2010 10:34 pm | by San Diego Business Journal | Comments

The UC San Diego Health System has been designated as a Blue Distinction Center for Spine Surgery as well as for Knee and Hip Replacement.

TOPICS:

The Key Ingredient to Effective Cancer Treatments

November 23, 2010 7:34 pm | by Massachusetts Institute of Technology | Comments

A startup is developing oxygen-carrying compounds that it says could make radiation therapy more effective in half of all cancer patients.

Daily dose of HIV drug reduces risk of HIV infection

November 23, 2010 1:35 pm | by EurekAlert | Comments

(NIH/National Institute of Allergy and Infectious Diseases) A daily dose of an oral antiretroviral drug, currently approved to treat HIV infection, reduced the risk of acquiring HIV infection by 43.8 percent among men who have sex with men. The findings, a major advance in HIV...

TOPICS:
Advertisement

21 group leaders join network of EMBO Young Investigators

November 23, 2010 10:42 am | by EurekAlert | Comments

(European Molecular Biology Organization) Today, the European Molecular Biology Organization announced the selection of 21 of Europe's most talented young researchers as 2010 beneficiaries of the EMBO Young Investigator Programme.

TOPICS:

Cigarette smoking increases rheumatoid arthritis risk in African-Americans

November 23, 2010 10:42 am | by EurekAlert | Comments

(Wiley-Blackwell) A new study determined that African-Americans who smoke cigarettes have a higher risk of developing rheumatoid arthritis (RA). RA risk is more pronounced among individuals positive for the HLA-DRB1 shared epitope, a genetic risk factor for RA. Findings from this...

TOPICS:

Early diagnosis of rheumatoid arthritis crucial to positive outcomes for patients(2)

November 23, 2010 10:42 am | by EurekAlert | Comments

(Wiley-Blackwell) Positive outcomes in rheumatoid arthritis (RA) are closely linked to early diagnosis and treatment with disease-modifying antirheumatic drugs (DMARDs). A study by researchers in the Netherlands found that patients who are assessed by rheumatologists soon after RA...

TOPICS:

Aushon BioSystems appoints Beushausen as CSO

November 23, 2010 10:39 am | by Mass High Tech: The Journal of New England Technology | Comments

Aushon Biosytems Inc., a biotechnology services company, has named Sven Beushausen, a former molecular medicine site lead for Pfizer Inc., as its new chief scientific officer.

Advertisement

Study prescribes Medicare 2011 drug plan research

November 23, 2010 9:46 am | by TOM MURPHY - AP Business Writer - Associated Press | Comments

Medicare prescription drug customers should closely study 2011 coverage options before they renew their plans, according to the research firm Avalere Health, which forecasts significant changes in the coming year.Many plans have changed the drugs they cover or the amounts consumers pay, and...

TSX-listed corporate dividends and distributions declared Nov. 23, 2010

November 23, 2010 9:45 am | by The Associated Press | Comments

Dividends or distributions were declared or updated on the followed listed issues on the Toronto Stock Exchange on Nov. 23, 2010.Canadian Real Estate Investment Trust Units (TSX:REF.UN): $0.115. Payable Jun 14. Record May 31.Ag Growth International Inc. (TSX:AFN): $0.2. Payable Dec 30. Record...

Discera?s silicon oscillators are the first to deliver 10 ppm accuracy for consumer applications

November 23, 2010 9:37 am | by I-Micronews | Comments

Semiconductor-grade reliability of 2.6 billion hour MTBF is over 2x better than MEMS industry, over 20x better than crystal oscillators.

Vertex forwards hepatitis C treatment for FDA approval

November 23, 2010 9:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Vertex Pharmaceuticals Inc. said it has finished submitting its hepatitis C drug candidate to the U.S. Food and Drug Administration for approval. The submission is widely seen as a watershed moment for the company because the drug, if approved, is expected to be a blockbuster.

FDA approves BG Medicine heart failure test

November 23, 2010 9:34 am | by Mass High Tech: The Journal of New England Technology | Comments

BG Medicine Inc. has received approval from the U.S. Food and Drug Administration for its cardiac test, Galectin-3, which is designed to measure galectin-3 blood levels.

TOPICS:

Summary Box: Medtronic profit falls in 2nd quarter

November 23, 2010 8:46 am | by The Associated Press | Comments

LEGAL HIT: Medtronic, the world's largest medical device maker, reported a 35 percent drop in profit for the second quarter as legal expenses tied to defective heart devices outpaced weak gains in medical device sales.DEVICE DEMAND: The company lowered its earnings guidance for the second half of...

MEMSIC introduces METF2000 series of MEMS gas mass flow meters for industrial applications

November 23, 2010 8:37 am | by I-Micronews | Comments

MEMSIC, Inc. /quotes/comstock/15*!mems/quotes/nls/mems (MEMS 3.00, +0.06, +2.04%) , a leading innovator of MEMS sensors and systems solutions, today announced its first generation family of high-performance MEMS Gas Mass Flow Meters.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading